Ads by Google
With a skin cancer rate among the 10 highest in the nation, Utah health officials are urging residents to take steps to keep their skin safe. Utah Department of Health (UDOH) data show that the rate of melanoma--the deadliest form of skin cancer--is increasing. In 2005, 554 Utahns were diagnosed with melanoma, up from 494 in 2004. Every year, melanoma kills an average of 63 Utah residents.
The good news is that skin cancer is preventable when sun protection measures are used consistently. UDOH and the Utah Cancer Action Network (UCAN) recommend:
Patient's own infection-fighting T cells put late-stage melanoma into long-term remission - without chemotherapy or radiation. Case is first to show safety and effectiveness of using cloned cells alone to kill tumors.
Disabling a protein frequently found in melanoma tumors may make the cancer more vulnerable to chemotherapy.
Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients treated with Leukine (sargramostim) achieved disease-free and/or overall survival. These findings, which indicate Leukine's potential in this cancer setting, were released at the 44th annual meeting of the American Society of Clinical Oncology (ASCO).
Results from the Phase II study (ASCO abstract #20027) show that 60 percent of the 45 high-risk patients enrolled in the trial experienced disease-free survival and 64 percent of patients achieved overall survival at 21 months.
In this study, Genasense was used to potentially enhance the clinical activity of temozolomide, the most commonly used anticancer drug for melanoma, combined with Abraxane.
Scientists are urging everyone to take safety measures against sun rays during this summer and to protect themselves from skin cancer.
deCODE scientists and academic colleagues from Europe and US expand upon the company's recent findings in the genetics of pigmentation traits in people of European descent, and demonstrate that certain of these common variants also confer risk of two types of skin cancer.
The point of entry for skin cancer in response to sun exposure is in receptor molecules, molecular "hooks" on the outer surface of cells that also pull cannabinoid compounds found in marijuana out of the bloodstream.
While occupational risks are inherent in many jobs, workers who make a living toiling in the sun face an increased threat of skin cancer from repeated overexposure to the sun's harmful ultraviolet (UV) rays.
When detected early, most skin cancers can be successfully treated.
Researchers have discovered how a mole develops into melanoma by showing the interaction of two key proteins involved in 60-70 percent of tumors. Melanoma is the most deadly form of skin cancer because it metastasizes or moves around the body so quickly.
In a demonstration that even some of the most hard-to-treat tumors may one day succumb to therapies aimed at molecular 'weak points'.
May is national skin cancer awareness month. TOPEX, Inc. located in Danbury, CT is helping to fight this disease with a low energy or superficial x-ray therapy system specially designed for this treatment procedure. This new system provides an alternative to surgery for treating basal cell and squamous cell carcinomas, especially for primary lesions requiring difficult or extensive surgery with sensitive structures in the head and neck regions -- the fold in the nose, eyelids, lips, corner of the mouth, and the lining of the ear that would otherwise lead to a poor cosmetic outcome.
An unusual form of skin cancer may be a sign of an underlying syndrome that makes people more susceptible to certain other cancers.
A proprietary blend extracted from canola, Dermytol, produces a pronounced reduction of malignant melanoma cell growth.
Melanomas could be treated using an anti-tumour protein, reports The Guardian, adding that the protein puts cells into hibernation or makes them commit suicide if they start to get cancerous. This research could be used as a new way to threat the notoriously aggressive cancer, the article adds.
As the number of organ transplants continues to increase throughout the world, so too are the number of organ transplant recipients developing skin cancer. Due in large part to the immunosuppressive medications required to prevent organ rejection, skin cancer among patients receiving solid organ transplants -- such as kidney, heart, liver, or lung, among other organs -- also tends to be more aggressive and spreads more quickly than in other patients.